BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 525272)

  • 1. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin levels and bromocriptine treatment of short luteal phase.
    Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
    Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolactin and bromocriptine on the luteal phase in infertile women.
    Fredricsson B; Carlström K; Björk G; Messinis I
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):319-33. PubMed ID: 6785120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin and deficient luteal function.
    del Pozo E; Wyss H; Tollis G; Alcañiz J; Campana A; Naftolin F
    Obstet Gynecol; 1979 Mar; 53(3):282-6. PubMed ID: 424097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine.
    Atasü T; Kösebay D; Aksu F
    Curr Med Res Opin; 1988; 11(1):56-63. PubMed ID: 3383612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum levels of FSH, LH and prolactin in luteal phase inadequacy.
    Minakami H; Kimura K; Tamada T
    Endocrinol Jpn; 1985 Apr; 32(2):265-70. PubMed ID: 3930224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of transient or occult hyperprolactinemia on luteal function].
    Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.
    Andersch B; Abrahamsson L; Wendestam C; Ohman R; Hahn L
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):657-64. PubMed ID: 575318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
    Aisaka K; Yoshida K; Mori H
    Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen in the treatment of infertility associated with luteal phase deficiency.
    Fukushima T; Tajima C; Fukuma K; Maeyama M
    Fertil Steril; 1982 Jun; 37(6):755-61. PubMed ID: 6806128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on prolactin secreting capacity in the ovulatory infertile patients with transient hyperprolactinemia].
    Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):662-71. PubMed ID: 3089848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of bromocriptine treatment on prolactin secretion in infertile women with suspicion of luteal phase insufficiency].
    Krzemiński A; Sikorski R; Woźniak S
    Ginekol Pol; 1998 Dec; 69(12):1141-5. PubMed ID: 10224791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteotropic effects of tamoxifen in infertile women.
    Tajima C
    Fertil Steril; 1984 Aug; 42(2):223-7. PubMed ID: 6430723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.